Covaxin Human Trials: Delhi’s Dr Dangs Lab To Partner With Bharat Biotech
A Delhi-based private laboratory, Dr Dangs Lab, has claimed that it has been selected as the central lab for human clinical trials of Covaxin, India's indigenous COVID-19 vaccine candidate. The vaccine is being developed and manufactured by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology(NIV) Pune.
Dr. Dangs Lab said on Wednesday that it has partnered with Bharat Biotech for conducting the trials.
"We are extremely privileged to announce that Dr. Dangs Lab, New Delhi has been provided the opportunity to serve the nation by being selected as the central lab for the Human Clinical trials of Covaxin; India's indigenous COVID-19 vaccine being developed and manufactured by Bharat Biotech in collaboration with the ICMR, NIV," Dr Dang's Lab said in a statement.